Showing results (51-60 of 123) with videos related to
Sort By:
Pageof 13
Journal of Managed Care & Specialty Pharmacy|April 14, 2020
Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer DatabaseBhavik J Pandya, Chi-Chang Chen, Bruno C Medeiros, et al.International Journal of Hematology|May 27, 2018
A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myelomaShira Dinner, Tamara J Dunn, Elizabeth Price, et al.Haematologica|October 22, 2013
Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II studyRoland B Walter, Bruno C Medeiros, Kelda M Gardner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2017
Effects of Education and Income on Treatment and Outcome in Patients With Acute Myeloid Leukemia in a Tax-Supported Health Care System: A National Population-Based Cohort StudyLene Sofie Granfeldt Østgård, Mette Nørgaard, Bruno C Medeiros, et al.Frontiers in Oncology|May 19, 2023
CD25 targeting with the afucosylated human IgG1 antibody RG6292 eliminates regulatory T cells and CD25+ blasts in acute myeloid leukemiaLaurène Pousse, Koorosh Korfi, Bruno C Medeiros, et al.Oncotarget|October 13, 2016
Autophagy mediates proteolysis of NPM1 and HEXIM1 and sensitivity to BET inhibition in AML cellsMin Huang, Jacqueline S Garcia, Daniel Thomas, et al.British Journal of Haematology|February 6, 2016
Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988-2011: a population-based studyRenata Abrahão, Ruth H Keogh, Daphne Y Lichtensztajn, et al.Clinical Epidemiology|November 8, 2019
Longer distance to specialized treatment centers does not adversely affect treatment intensity or outcomes in adult acute myeloid leukemia patients. A Danish national population-based cohort studyMichael Tøstesen, Mette Nørgaard, Jan Maxwell Nørgaard, et al.Haematologica|October 14, 2011
Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemiaMichaela Liedtke, Clare J Twist, Bruno C Medeiros, et al.Current Medical Research and Opinion|February 5, 2019
Treatment patterns in patients with acute myeloid leukemia in the United States: a cross-sectional, real-world surveyBruno C Medeiros, Bhavik J Pandya, Anna Hadfield, et al.Pageof 13